Penn Medicine Researchers Are Developing a Blood Test for Those at Highest Risk of Kidney Disease
Researchers are developing a blood test to better predict the risk of kidney disease in Black Americans who carry high-risk APOL1 gene variants.
Penn Medicine’s Virginia Lee to Retire after Prolific Career
She leaves behind a lasting legacy in brain disease research, with discoveries that are drastically transforming the scientific understanding of diseases like Alzheimer's Disease and ALS.
Three Penn Medicine Faculty Members Make Forbes List of 250 of America’s Greatest Innovators
They were recognized for developing groundbreaking ideas and businesses that transformed society.
A New Hub for AI-Driven RNA Research Opens at Penn
Penn’s newest collaborative institution is the U.S. National Science Foundation Artificial Intelligence-driven RNA BioFoundry (NSF AIRFoundry), which uses AI to improve, accelerate, and scale the desi
Federal Small Business Programs Reauthorized
The Small Business Innovation and Economic Security Act reauthorized and updated the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Top 10 U.S. Biopharma Clusters 2026 ranks Philadelphia #5
The region rose two spots this year and was recognized for growth in lab space, NIH funding, venture capital, patent rankings, and industry attraction.
Penn Ranks #3 in Cure Healthcare Innovation Index
The index evaluates how effectively institutions turn scientific research into real-world medical and commercial impact.
Vasowatch Seeks FDA Clearance for Postpartum Prediction Tools
The company is developing predictive software that transforms existing wearables into early-warning tools for postpartum hemorrhage.
New Clinical Data Move Cabaletta Closer to First Autoimmune CAR-T Approval
The company reported encouraging clinical data for its CAR T-cell therapy, RESE-CEL™.